Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Hepatobiliary Diseases Topic Center

Featured Article

Agopian
Conference Coverage
Integrating Surgical and Systemic Approaches to HCC
01/10/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Dr Vatche G. Agopian provided an overview of how surgery and systemic therapy can be combined to improve outcomes for patients with hepatocellular carcinoma at the International Society of Gastrointestinal Cancer meeting on October 13.
Dr Vatche G. Agopian provided an overview of how surgery and systemic therapy can be combined to improve outcomes for patients with hepatocellular carcinoma at the International Society of Gastrointestinal Cancer meeting on October 13.
Dr Vatche G. Agopian provided an...
01/10/2024
Gastroenterology
liver
Conference Coverage
Mixed CCA/HCC Tumors: A Real Thing
10/17/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed...
10/17/2023
Gastroenterology
Nilofer Azad
Conference Coverage
Biliary Tract Cancer: Where Are We Headed?
10/14/2023

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Dr Nilofer Azad of Johns Hopkins University reviewed the progress and unmet needs for treatment of biliary tract cancer at the International Society of Gastrointestinal Oncology conference in Tempe, Arizona.
Dr Nilofer Azad of Johns Hopkins University reviewed the progress and unmet needs for treatment of biliary tract cancer at the International Society of Gastrointestinal Oncology conference in Tempe, Arizona.
Dr Nilofer Azad of Johns Hopkins...
10/14/2023
Gastroenterology
Quiz
Combo Therapy for uHCC
08/16/2023
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
Researchers have found a combination of two agents to demonstrate superior efficacy and a favorable benefit-risk profile among patients with unresectable hepatocellular carcinoma. Take our quiz to find out which combo could improve overall...
Researchers have found a...
08/16/2023
Gastroenterology
News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
Infusion
News
ICIs Analyzed as First-Line Therapies for HCC
03/22/2023
Investigators conducted a systematic review and network meta-analysis to determine whether immune checkpoint inhibitors evidenced efficacy and safety as first-line agents for the treatment for unresectable hepatocellular carcinoma.
Investigators conducted a systematic review and network meta-analysis to determine whether immune checkpoint inhibitors evidenced efficacy and safety as first-line agents for the treatment for unresectable hepatocellular carcinoma.
Investigators conducted a...
03/22/2023
Gastroenterology
Liver drawing
News
Predictors of Immunotherapy Response in Hepatobiliary Malignancies Remain Elusive
03/16/2023
The search continues for biomarkers that will help identify patients likely to respond to immunotherapy for hepatobiliary cancer.
The search continues for biomarkers that will help identify patients likely to respond to immunotherapy for hepatobiliary cancer.
The search continues for...
03/16/2023
Gastroenterology
Coffee
Quiz
Quiz: Screening for HCC
03/14/2023
What did the findings of a recent study show regarding the screening of patients with nonalcoholic fatty liver disease-related cirrhosis for hepatocellular carcinoma?
What did the findings of a recent study show regarding the screening of patients with nonalcoholic fatty liver disease-related cirrhosis for hepatocellular carcinoma?
What did the findings of a...
03/14/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology

News

News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology
News
Durvalumab Plus Tremelimumab Improves Survival in Unresectable HCC
01/17/2023
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab...
01/17/2023
Gastroenterology
News
Disparities in Access to Immunotherapy for HCC
01/13/2023
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are...
01/13/2023
Gastroenterology
News
Patient-Reported Barriers to HCC Surveillance
01/04/2023
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in...
01/04/2023
Gastroenterology
News
Robotic Liver Resection for Hepatocellular Carcinoma Offers Oncologic Efficacy, Safety
12/28/2022
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers...
12/28/2022
Gastroenterology
News
CCA Diagnostic Tools Reviewed for Comparative Sensitivity
12/19/2022
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of...
12/19/2022
Gastroenterology
News
Did the Pandemic Affect HCC Surveillance?
11/29/2022
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find...
11/29/2022
Gastroenterology
News
Novel AI System Shows Success in Detection of Adenomas
08/27/2024
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system...
08/27/2024
Gastroenterology
News
Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening
08/20/2024
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether...
08/20/2024
Gastroenterology
News
Low-Dose Aspirin and Prevention of Colorectal Cancer
08/14/2024
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed...
08/14/2024
Gastroenterology
News
FIT Screening Associated With Lower Risk of Death From CRC
08/06/2024
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support...
08/06/2024
Gastroenterology
FDA
News
FDA Approves First Blood Test for Primary CRC Screening
07/30/2024
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test...
07/30/2024
Gastroenterology
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
News
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network

Videos

Alan Bonder
Conference Coverage
Alan Bonder, MD, on Primary Biliary Cholangitis
01/05/2022
Alan Bonder, MD, medical director of liver transplantation at Beth Israel Deaconess Medical Center in Boston, discusses key presentations of research on primary biliary cholangitis presented at the 2021 meeting of the American Association for...
Alan Bonder, MD, medical director of liver transplantation at Beth Israel Deaconess Medical Center in Boston, discusses key presentations of research on primary biliary cholangitis presented at the 2021 meeting of the American Association for...
Alan Bonder, MD, medical...
01/05/2022
Gastroenterology
Bill Chey
Videos
William Chey, MD, on the Role of Diet in Disorders of Gut-Brain Interaction
07/30/2024
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation...
07/30/2024
Gastroenterology
Video
Kayla Monks, MS, RD, on Nutrition for Patients With Liver Disease
06/14/2024
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses...
06/14/2024
Gastroenterology
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on the SEQUENCE Study
06/03/2024
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results...
06/03/2024
Advances in Inflammatory Bowel Disease Network
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Food Allergies and Sensitivities
11/22/2023
Dr Brian Lacy of Mayo Clinic-Florida dispels some myths and clarifies the issues surrounding food allergies and food sensitivities and provides guidance in how to treat both conditions.
Dr Brian Lacy of Mayo Clinic-Florida dispels some myths and clarifies the issues surrounding food allergies and food sensitivities and provides guidance in how to treat both conditions.
Dr Brian Lacy of Mayo...
11/22/2023
Gastroenterology
Conference Coverage
Paul Kwo, MD, on the Changing Face of Liver Disease
10/23/2023
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun...
10/23/2023
Gastroenterology
Rena Yadlapati
Conference Coverage
Rena Yadlapati, MD, on the Difficult-to-Treat Patient With GERD
10/23/2023
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance in the options for caring for patients who present with GERD that does not respond adequately to treatment.
Dr Yadlapati provides guidance...
10/23/2023
Gastroenterology
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Tenapanor for IBS-C
10/23/2023
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of...
10/23/2023
Gastroenterology
Aasma Shaukat
Conference Coverage
45 is the New 50: Aasma Shaukat, MD, on Meeting Demands for CRC Screening
10/22/2023
Dr Shaukat recaps her presentation on the increasing numbers of patients who will need screening colonoscopy now that the beginning age for colorectal screening has been lowered to 45 from 50, and methods that gastroenterology can take as a...
Dr Shaukat recaps her presentation on the increasing numbers of patients who will need screening colonoscopy now that the beginning age for colorectal screening has been lowered to 45 from 50, and methods that gastroenterology can take as a...
Dr Shaukat recaps her...
10/22/2023
Gastroenterology
Blanca Lizaolo-Mayo
Video
Blanca Lizaola-Mayo, MD, on Changes in Nomenclature for Liver Diseases
09/20/2023
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the...
09/20/2023
Gastroenterology
Sarah Khan
Video
Sarah Khan, MD, on Outcomes in Liver Patients With Fungal and Bacterial Infection
05/15/2023
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of...
05/15/2023
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Imaging, Biomarkers May Improve Hepatocellular Carcinoma Surveillance
03/30/2023
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and blood-based biomarker panels offer promise for better hepatocellular carcinoma surveillance.
Imaging modalities and...
03/30/2023
Gastroenterology
News
Gastrointestinal, Hepatic Manifestations Affect Many with COVID-19
03/02/2023
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause direct viral infection of the liver and some treatments for COVID-19 may also cause gastrointestinal and liver complications.
The SARS-CoV-2 virus may cause...
03/02/2023
Gastroenterology
News
HIMALAYA Trial Examines Treatment-Emergent ADAs for Durvalumab in HCC Regimens
02/24/2023
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may inhibit antitumor activity in hepatocellular carcinoma. A trial of durvalumab in the STRIDE regimen sought to see how the drug performed.
Immune checkpoint inhibitors may...
02/24/2023
Gastroenterology
News
Biomarkers To Predict ICI Response in Hepatobiliary Cancers “Urgently” Needed
02/08/2023
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates that reliable predictors of response to immune checkpoint inhibitors for treatment of hepatobiliary malignancies remains an unmet need.
A literature review indicates...
02/08/2023
Gastroenterology
News
Durvalumab Plus Tremelimumab Improves Survival in Unresectable HCC
01/17/2023
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab combined with tremelimumab appears to initiate clinical response among patients with unresectable hepatocellular carcinoma, according to results of a the HIMALAYA trial.
A single dose of durvalumab...
01/17/2023
Gastroenterology
News
Disparities in Access to Immunotherapy for HCC
01/13/2023
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are less likely to receive immunotherapy for advanced hepatocellular carcinoma, according to a recent review.
Black and Hispanic patients are...
01/13/2023
Gastroenterology
News
Patient-Reported Barriers to HCC Surveillance
01/04/2023
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in Clinical Gastroenterology and Hepatology evaluated the effects of patient-level factors on hepatocellular carcinoma surveillance receipt.
A recent study published in...
01/04/2023
Gastroenterology
News
Robotic Liver Resection for Hepatocellular Carcinoma Offers Oncologic Efficacy, Safety
12/28/2022
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers advantages over open liver resection in patients with hepatocellular carcinoma in expert centers, according to study findings published online ahead of print in JAMA Surgery.
Robotic liver resection offers...
12/28/2022
Gastroenterology
News
CCA Diagnostic Tools Reviewed for Comparative Sensitivity
12/19/2022
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of cholangiocarcinoma diagnosis, both biopsy and biomarkers may be required.
To improve the accuracy of...
12/19/2022
Gastroenterology
News
Did the Pandemic Affect HCC Surveillance?
11/29/2022
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find out if the pandemic had an impact, negative or positive, on surveillance for hepatocellular carcinoma among patients with liver disease showed some puzzling results.
A retrospective study to find...
11/29/2022
Gastroenterology
News
Novel AI System Shows Success in Detection of Adenomas
08/27/2024
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.
CAD-EYE detection system...
08/27/2024
Gastroenterology
News
Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening
08/20/2024
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.
Investigators studied whether...
08/20/2024
Gastroenterology
News
Low-Dose Aspirin and Prevention of Colorectal Cancer
08/14/2024
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.
Results of a new study showed...
08/14/2024
Gastroenterology
News
FIT Screening Associated With Lower Risk of Death From CRC
08/06/2024
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.
Findings of a new study support...
08/06/2024
Gastroenterology
FDA
News
FDA Approves First Blood Test for Primary CRC Screening
07/30/2024
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.
Shield is the first blood test...
07/30/2024
Gastroenterology
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
News
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement